The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2512-2519

  Cohen, Gerald ^a   Raupachova, Jana ^a   Wimmer, Thomas ^a   Deicher, Robert ^a   Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Haemodialysis; Intracellular calcium; Polymorphonuclear leukocytes; Uraemia

Indexed keywords

4 HYDROXY HIPPURIC ACID; ADENOSINE TRIPHOSPHATASE INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPIAZONIC ACID; DNA; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FURA 2; HIPPURIC ACID DERIVATIVE;

ADULT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; ENDOPLASMIC RETICULUM; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEMODIALYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; NEUTROPHIL; PRIORITY JOURNAL; UREMIA;

APOPTOSIS; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CASPASES; ENZYME INHIBITORS; HIPPURATES; HUMANS; INDOLES; KIDNEY FAILURE, CHRONIC; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PHYTOHEMAGGLUTININS; RENAL DIALYSIS; TOXINS, BIOLOGICAL; UREMIA;

EID: 48749097256     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn098     Document Type: Article

References (48)

1. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006; 19: 291-296
2. Mahajan S, Kalra OP, Asit KT et al. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren Fail 2005; 27: 357-360
3. Sardenberg C, Suassuna P, Andreoli MC et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006; 21: 160-165
4. Yao Q, Axelsson J, Stenvinkel P et al. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. Asaio J 2004; 50: lii-lvii
5. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33
6. Scannell M, Maderna P. Lipoxins and annexin-1: resolution of inflammation and regulation of phagocytosis of apoptotic cells. Scientific World J 2006; 6: 1555-1573
7. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6: 1191-1197
8. Cohen G, Rudnicki M, Hörl WH. Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int 2001; 59: S48-S52
9. Cohen G, Rudnicki M, Hörl WH. Isolation of modified ubiquitin as a neutrophil chemotaxis inhibitor from uremic patients. J Am Soc Nephrol 1998; 9: 451-456
10. Cohen G, Hörl WH. Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions. Eur J Clin Invest 2004; 34: 774-781
11. Cohen G, Rudnicki M, Deicher R et al. Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis. Eur J Clin Invest 2003; 33: 669-676
12. Cohen G, Rudnicki M, Walter F et al. Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes. J Am Soc Nephrol 2001; 12: 1264-1271
13. 2+-ATPase in end-stage renal failure. Kidney Int Suppl 2001; 78: S84-S88
14. Anderson R, Goolam Mahomed A. Calcium efflux and influx in f-met-leu-phe (fMLP)-activated human neutrophils are chronologically distinct events. Clin Exp Immunol 1997; 110: 132-138
15. Pettit EJ, Hallett MB. Nonuniform distribution of Ca(2+) uptake sites within human neutrophils. Biochem Biophys Res Commun 2000; 279: 337-340
16. 2+ in human neutrophil responses to receptor agonists. Biochem J 1991; 277(Pt 3): 705-711
17. Lucas M, Diaz P. Thapsigargin-induced calcium entry and apoptotic death of neutrophils are blocked by activation of protein kinase C. Pharmacology 2001; 63: 191-196
18. Ward RA, McLeish KR. Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrol Dial Transplant 2004; 19: 1702-1707
19. Hirayama A, Noronha-Dutra AA, Gordge MP et al. Inhibition of neutrophil superoxide production by uremic concentrations of guanidino compounds. J Am Soc Nephrol 2000; 11: 684-689
20. Glorieux GL, Dhondt AW, Jacobs P et al. In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 2004; 65: 2184-2192
21. Cohen G, Haag-Weber M, Mai B et al. Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions. J Am Soc Nephrol 1995; 6: 1592-1599
22. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943
23. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450
24. Jaber BL, Perianayagam MC, Balakrishnan VS et al. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J Leukoc Biol 2001; 69: 1006-1012
25. Cendoroglo M, Jaber BL, Balakrishnan VS et al. Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999; 10: 93-100
26. Koller H, Hochegger K, Zlabinger GJ et al. Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system. Nephrol Dial Transplant 2004; 19: 3104-3111
27. De Smet R, Vogeleere P, Van Kaer J et al. Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serumof uremic patients. J Chromatogr A 1999; 847: 141-153
28. Trevani AS, Andonegui G, Giordano M et al. Extracellular acidification induces human neutrophil activation. J Immunol 1999; 162: 4849-4857
29. Bouts AH, Krediet RT, Davin JC et al. IGG and complement receptor expression on peripheral white blood cells in uraemic children. Nephrol Dial Transplant 2004; 19: 2296-2301
30. Ando M, Shibuya A, Tsuchiya K et al. Reduced capacity of mononuclear cells to synthesize cytokines against an inflammatory stimulus in uremic patients. Nephron Clin Pract 2006; 104: c113-c119
31. Ando M, Shibuya A, Tsuchiya K et al. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int 2006; 70: 358-362
32. Ando M, Shibuya A, Yasuda M et al. Impairment of innate cellular response to in vitro stimuli in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005; 20:2497-2503
33. Gibbons RA, Martinez OM, Garovoy MR. Altered monocyte function in uremia. Clin Immunol Immunopathol 1990; 56: 66-80
34. Haag-Weber M, Mai B, Hörl WH. Effect of hemodialysis on intracellular calcium in human polymorphonuclear neutrophils. Miner Electrolyte Metab 1992; 18: 151-155
35. i and carbohydrate metabolism of PMNL of dialysis patients. Kidney Int 1995; 47: 1741-1745
36. Kettritz R, Falk RJ, Jennette JC et al. Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis. J Am Soc Nephrol 1997; 8:1091-1100
37. Hu TH, Bei L, Huang YF et al. The relationship between fMLP induced neutrophil respiratory burst and the apoptosis of neutrophil. Shi Yan Sheng Wu Xue Bao 1999; 32: 359-366
38. Deicher R, Kirsch B, Müllner M et al. Impact of parathyroidectomy on neutrophil cytosolic calcium in chronic kidney disease patients: a prospective parallel group trial. J Intern Med 2005; 258:67-76
39. Karpati I, Seres I, Matyus J et al. Which parameters affect cytosolic free calcium in polymorphonuclear leukocytes of haemodialysis patients? Nephrol Dial Transplant 2001; 16: 1409-1415
40. Koorts AM, Kruger MC, Potgieter CD et al. Intracellular free calcium in the neutrophils of maintenance haemodialysis patients. Clin Physiol Funct Imaging 2002; 22: 285-294
41. Haag-Weber M, Hörl WH. Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 1996; 16: 192-201
42. Massry S, Smogorzewski M. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone. Kidney Int Suppl 2001; 78: S195-S196
43. Hansch GM, Karnaoukhova S, Chang SH et al. Activation of human neutrophils after contact with cellulose-based haemodialysis membranes: intracellular calcium signalling in single cells. Nephrol Dial Transplant 1996; 11: 2453-2460
44. 2+ elevation in neutrophils by thiol-oxidizing phenylarsine oxide. Biochem Pharmacol 2005; 69: 1225-1234
45. 2+ entry in neutrophils. Biochem Pharmacol 2003; 65: 1923-1929
46. 2+/calmodulin regulated signaling pathways in chemoattractant induced neutrophil effector functions. Comparison with the role of phosphotidylinositol-3 kinase. Eur J Biochem 2002; 269: 4625-4634
47. Klein JB, Buridi A, Coxon PY et al. Role of extracellular signal-regulated kinase and phosphatidylinositol-3 kinase in chemoattractant and LPS delay of constitutive neutrophil apoptosis. Cell Signal 2001; 13: 335-343
48. Chacon-Cruz E, Oelberg DG, Davis P et al. Membrane depolarization and depletion of intracellular calcium stores are associated with delay of apoptosis in human neutrophils. J Leukoc Biol 1998; 64: 759-766